Broncus Holding Corp Sustainability Reports
The company operates as a medical device enterprise specializing in the development and commercialization of navigation systems, diagnostic software, and therapeutic consumables for interventional pulmonology. Its portfolio primarily targets the treatment of chronic obstructive pulmonary disease and lung cancer.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG00DRMY8H0
5 reports from 2021 to 2025
